You are here: Industry Insights > WHO

News List

White paper calls for action on AMR expresspharma
July 30, 2021
A group of researchers led by Professor Nirmal Kumar Ganguly, Former Director-General, Indian Council of Medical Research (ICMR), have come out with a white paper on AMR, as it threatens to become the next big public health crisis in India and ...
Celltrion’s monoclonal antibody treatment for COVID-19 works against Delta variant: Study expresspharma
July 19, 2021
Regdanvimab (CT-P59) also retained its neutralisation potency against the Lambda variant (C.37, first identified in Peru) using a pseudo-virus neutralisation assay.
A Drop for Clear Vision: Japan Has Surpassed Itself Again with the Development of Ultra-High-Concentration Lutein prnasia
July 14, 2021
According to the World Report on Vision published in 2020 by World Health Organization (WHO), the incidence of most eye diseases and visual impairments varies by age, area of residence, and income level.
WHO publishes recommendations on human genome editing europeanpharmaceuticalreview
July 14, 2021
To promote the safe and ethical use of genome editing for the treatment of disease and genetic disorders WHO has published the first global recommendations.
Get COVID-19 Vaccines to Poor Nations Instead of Making Booster Shots: WHO drugs
July 14, 2021
COVID-19 vaccine makers such as Pfizer should focus on getting shots to poor countries instead of trying to persuade wealthy nations to give their citizens booster shots, World Health Organization (WHO) officials said at a press briefing held Monday.
WHO: Get COVID-19 Vaccines to Poor Nations Instead of Making Booster Shots drugs
July 14, 2021
COVID-19 vaccine makers such as Pfizer should focus on getting shots to poor countries instead of trying to persuade wealthy nations to give their citizens booster shots, World Health Organization officials said at a press briefing held Monday.
WHO Calls for Global Registry of Human Genome Editing drugs
July 13, 2021
New recommendations on human genome editing issued by the World Health Organization include a call for a global registry to track "any form of genetic manipulation" and a whistle-blowing process for unethical or unsafe research.
Documents for Covaxin emergency use listing submitted to WHO; expect approval at earliest: Bharat Biotech firstwordpharma
July 13, 2021
Bharat Biotech on Monday said it has submitted all documents required for the emergency use listing of its COVID-19 vaccine Covaxin to the World Health Organization (WHO), as reported by The Economic Times.
Wearing A Mask Still Matters: The World Rallies to Continue Masking to Stop the Spread of COVID-19 prnewswire
July 13, 2021
Pandemic Action Network, the Africa Centres for Disease Control and Prevention (Africa CDC), the African Union, 3M and over 50 global, regional, and local partner organizations announced today the launch of World Mask Week 2021.
WHO is likely to decide on EUL of Covaxin in four to six weeks expresspharma
July 12, 2021
According to WHO guidelines, EUL is a procedure to streamline the process by which new or unlicensed products can be used during public health emergencies.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page